The novel idea of bioresorbable stent technology continues to fascinate the interventional community. This article aims to provide a concise and balanced overview of the available technology and clinical evidence. Both potentially positive and negative aspects of bioresorbable stents in different lesion subsets and clinical situations are discussed.
Viktor Kočka - Cardiocenter, Third Faculty of Medicine, Charles University, Prague, University Hospital Kralovske Vinohrady, Czech Republic
Petr Widimský - Cardiocenter, Third Faculty of Medicine, Charles University, Prague, University Hospital Kralovske Vinohrady, Czech Republic
